A Cost-Effective Agent for Clinical Trial Assignment Princeton K. Kokku Lawrence O. Hall Dmitry B. Goldgof Eugene Fink Jeffrey P. Krischer.

Slides:



Advertisements
Similar presentations
Evaluating health informatics projects Reasons for and problems of evaluation Objective model Subjective model.
Advertisements

Regulatory Clinical Trials Clinical Trials. Clinical Trials Definition: research studies to find ways to improve health Definition: research studies to.
Minority Clinical Trial Participant Webinar: Difficult Conversations Daniel E. Epner, M.D. General Oncology Department Medical Director, International.
How to Write a Research Proposal Detroit Medical Center Nursing Research Council.
SUTENT  (sunitinib malate) capsules Access Slide Kit.
Step 2: Locating the Evidence. Table of Contents Evidence Pyramid –Filtered InformationFiltered Information Systematic Reviews/Meta-AnalysesSystematic.
Clinical Trials Medical Interventions
Chicken Soup for the Busy Coordinator Nov 2010 PROTOCOL FEASIBILITY.
ClinicalTrials.gov Stephen Kiyoi
Selection of Clinical Trials: Knowledge Representation and Acquisition Committee: Eugene Fink Lawrence O. Hall Dmitry B. Goldgof Savvas Nikiforou.
Coding of Selection Criteria for Cancer Treatment Plans Savvas Nikiforou.
Knowledge Acquisition for Clinical-Trial Selection Savvas Nikiforou Eugene Fink Lawrence O. Hall Dmitry B. Goldgof Jeffrey P. Krischer.
1 Chapter 9 Rules and Expert Systems. 2 Chapter 9 Contents (1) l Rules for Knowledge Representation l Rule Based Production Systems l Forward Chaining.
Simplification Tactics Dr. Saeed Shiry Amirkabir University of Technology Computer Engineering & Information Technology Department.
A) The number of potentially eligible patients recruited to randomised clinical trials (RCTs) worldwide is low. Trials often fail to recruit target numbers.
BS704 Class 7 Hypothesis Testing Procedures
JEOPARDY! JEOPARDY! I Can’t Believe It’s Not JEOPARDY!
Cancer Clinical Trials: The Basics. 2 What Are Cancer Clinical Trials? Research studies involving people Try to answer scientific questions and find better.
An expert system is a package that holds a body of knowledge and a set of rules on a subject that has been gained from human experts. An expert system.
Clinical Trials The Way We Make Progress Against Disease.
Early Detection of breast cancer Anthony B. Miller, MD, FRCP Associate Director, Research, Dalla Lana School of Public Health, University of Toronto, Canada.
Expert Systems Infsy 540 Dr. Ocker. Expert Systems n computer systems which try to mimic human expertise n produce a decision that does not require judgment.
Study Design / Data: Case-Control, Descriptives Basic Medical Statistics Course: Module C October 2010 Wilma Heemsbergen
Clinical Trials. What is a clinical trial? Clinical trials are research studies involving people Used to find better ways to prevent, detect, and treat.
Utility of Post-Therapy Surveillance Scans in Diffuse Large B-Cell Lymphoma Thompson C et al. Proc ASCO 2013;Abstract 8504.
Testing People Scientifically.  Clinical trials are research studies in which people help doctors and researchers find ways to improve health care. Each.
Medical Expert Systems Eddie Lai. History  1950s – scientists tried to use computers for “probabilistic reasoning and statistical pattern recognition”
Quantitative Evaluation of Drug Name Safety Using Close-to-Reality Simulated Pharmacy Practice Sean Hennessy, PharmD, PhD Assistant Professor of Epidemiology.
Low dose chemotherapy with insulin (Insulin Potentiation Therapy) in combination with hormone therapy for treatment of castration resistant prostate cancer.
How do we know whether a marker or model is any good? A discussion of some simple decision analytic methods Carrie Bennette (on behalf of Andrew Vickers)
Warm-up A newspaper article about an opinion poll says that “43% of Americans approve of the president’s overall job performance.” Toward the end of the.
A Teaching Hospital Challenge: Balancing Patient Care and Medical Student Education [Insert Name of Presenter] Ethics Resource Center American Medical.
Impact of a Six Month Clinical Librarian Trial in a Tertiary Care Centre: a Controlled Study Elizabeth Aitken International Clinical.
Transparency in Searching and Choosing Peer Reviewers Doris DEKLEVA SMREKAR, M.Sc.Arch. Central Technological Library at the University of Ljubljana, Trg.
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins Chapter 9 Continuity of Care.
Secondary Translation: Completing the process to Improving Health Daniel E. Ford, MD, MPH Vice Dean Johns Hopkins School of Medicine Introduction to Clinical.
Focusing the question Janet Harris Cochrane Qualitative Research Methods Group ESQUIRE Qualitative Systematic Review Workshop University of Sheffield 6.
06/02/04DRAFT1. 06/02/04DRAFT2 QUESTIONS FOR PANEL Trial Design 1.The sponsor makes outcome comparisons between the selected subgroups of LVAS and control.
Automated Selection of Patients for Clinical Trials Eugene Fink Lawrence O. Hall Dmitry B. Goldgof Bhavesh D. Goswami Matthew Boonstra Jeffrey P. Krischer.
CRITICAL THINKING AND THE NURSING PROCESS Entry Into Professional Nursing NRS 101.
Module IV - Identification of Patients for Buprenorphine Treatment BUPRENORPHINE TREATMENT: A TRAINING FOR MULTIDISCIPLINARY ADDICTION PROFESSIONALS.
Finite Patient Horizon NYSPI1 Design of Local Investigations in Community Practice Settings: An Effectiveness / Cost-Effectiveness Framework.
Of An Expert System.  Introduction  What is AI?  Intelligent in Human & Machine? What is Expert System? How are Expert System used? Elements of ES.
Has been broadly defined as the generation of new knowledge using the scientific method to identify and deal with health problems.
HERA TRIAL: 2 Years versus 1 Year of Trastuzumab After Adjuvant Chemotherapy in Women with HER2-Positive Early Breast Cancer at 8 Years of Median Follow-Up.
Efficacy of Combination First Line Agents for Smoking Cessation Sneha Baxi, Pharm.D. Pharmacy Practice Resident University of Illinois at Chicago.
Dr. Sabine Brookman-May, MD, PhD Regional Therapeutic Area Expert Oncology (Europe, Middle East, Africa) - Janssen R&D Improving patients involvement in.
httpwww.youtube.com/watch?v=DhxD6sVQEYc:// The Drug Discovery Process.
PRAGMATIC Study Designs: Elderly Cancer Trials
Perceptions of a pharmacist in an ambulatory care setting
Access to Epinephrine for Self-Administration (EPI Rph)
Introduction.
Evidence-based Medicine
USING NATIONAL GUIDELINES FOR SCREENING, TREATMENT, AND FOLLOW-UP
CLINICAL PROTOCOL DEVELOPMENT
How to Write a Research Proposal
Enrolling in Clinical Trials
8. Causality assessment:
Clinical Trials Medical Interventions
Evidence-Based Practice I: Definition – What is it?
The Role of Statistics in Clinical Trials
Figure 2 Underreporting by physicians of specific treatment-associated symptoms by physicians in the TORCH trial Figure 2 | Underreporting by physicians.
Clinical Trials.
Jones SE et al. SABCS 2009;Abstract 5082.
Figure 1 Underreporting of treatment-related toxicities by physicians, relative to patients with either advanced-stage lung cancer, or early-stage breast.
Pragmatic RCTs and the Learning Healthcare System
Medical Students Documenting in the EMR
Figure A (online only) Flow diagram showing case recruitment, participation and follow up to the three year interview for the Prostate Cancer Care and.
Market entry and sizing for a medical technology company
Few patients with youth-onset type 2 diabetes are available to participate in clinical trials. Few patients with youth-onset type 2 diabetes are available.
Presentation transcript:

A Cost-Effective Agent for Clinical Trial Assignment Princeton K. Kokku Lawrence O. Hall Dmitry B. Goldgof Eugene Fink Jeffrey P. Krischer

Clinical Trials A clinical trial is an evaluation of a new treatment procedure Researchers recruit patients with appropriate health problems and medical histories

Gotay [1991] showed that only 39% of the eligible patients are selected for clinical trials Fallowfield et al. [1997] showed that less than 50% of the eligible patients are selected Selection of Subjects The selection of subjects for clinical trials is a manual procedure, and researchers may miss some of the eligible patients.

Medical Tests The total cost of related medical tests may depend on their ordering Finding the right ordering is usually a complex optimization problem

Expert System Automatic selection of subjects for clinical trials Cost-effective ordering of related tests Explanation of the reasons for acceptance or rejection

System Design Interface Knowledge base Inference rules Ordering of tests

Interface Entry of patients’ data Emulation of a doctor-patient interview Explanation of the eligibility decisions

Knowledge Base Tests and questions Eligibility criteria

Inference Rules The system includes inference rules suggested by physicians. Example: If the cancer stage is III or IV, then the cancer is invasive.

Ordering of Tests The system chooses the ordering of tests that reduces their expected total cost After getting the results of the first test, it revises the ordering of the remaining tests The ordering of tests is based on the test costs, number of trials that require each test, and structure of eligibility criteria

Adding patients Selecting clinical trials Entering initial data Entering medical data Revising medical data Entering Patients’ Data

Adding patients Selecting clinical trials Entering initial data Entering medical data Revising medical data Adding Patients Add a new patient Find an old patient

Adding patients Selecting clinical trials Entering initial data Entering medical data Revising medical data Selecting Clinical Trials Choose candidate trials View all available trials

Adding patients Selecting clinical trials Entering initial data Entering medical data Revising medical data Entering Initial Data Answer initial questions Change previous answers

Adding patients Selecting clinical trials Entering initial data Entering medical data Revising medical data Entering Medical Data Enter medical-test results View eligibility decisions

Experiments Twelve breast-cancer trials at the H. Lee Moffitt Cancer Center Retrospective data from 187 patients Current data from 74 patients

Finding Eligible Patients Retrospective data from 187 patients Missing Data Clinical Trial Same Matches New Matches

Missing Data Clinical Trial Same Matches New Matches Finding Eligible Patients Current data from 74 patients

Conclusions The system can help to identify eligible patients and increase the number of trial participants It can potentially reduce the cost of medical tests related to eligibility decisions

Future Work Conduct more experiments Add clinical trials for lung cancer Combine the implemented heuristics with probabilistic reasoning